BRIEF published on 02/04/2025 at 08:05, 8 days 19 hours ago Neovacs considers an exit from the stock market to optimize its assets Investors Funding Biopharmaceutical Arnity Exit From The Stock Exchange
BRIEF published on 01/21/2025 at 21:05, 22 days 6 hours ago Fundraising of €0.25 million by Néovacs Fundraising Shareholder Dilution Néovacs OCEANE-BSA Kinoid® Research
BRIEF published on 01/15/2025 at 20:05, 28 days 7 hours ago Adjustment of the nominal value at Neovacs Investment Capital Reduction Nominal Value Néovacs Stock Market Shares
BRIEF published on 12/18/2024 at 08:35, 1 month 25 days ago Fundraising by Neovacs Biotechnology Fundraising Dilution Néovacs OCEANE-BSA
BRIEF published on 09/18/2024 at 20:05, 4 months 24 days ago Fundraising of €0.25 million by Néovacs Biotechnology Fundraising Investment Dilution OCEANE-BSA
BRIEF published on 08/28/2024 at 23:05, 5 months 15 days ago Adjustment of the nominal value: Neovacs reduces its capital Financial Health Euronext Growth Capital Reduction Nominal Value Néovacs
BRIEF published on 07/04/2024 at 20:05, 7 months 8 days ago Termination of the financing contract granted to Pharnext Termination Funding Biopharmaceutical Pharnext Néovacs
BRIEF published on 06/17/2024 at 08:05, 7 months 25 days ago Néovacs collaborates with the CNRS to develop mRNA lipid formulations Scientific Collaboration Biomedical Research Néovacs CNRS Lipid Formulations Messenger RNA
Published on 02/13/2025 at 01:35, 1 hour 32 minutes ago Alset AI Provides Bi-Weekly MCTO Status Report
Published on 02/12/2025 at 23:30, 3 hours 37 minutes ago Focus Graphite Announces Amendment to Terms of Non-Brokered Private Placement and Extension of Closing Timeline
Published on 02/12/2025 at 22:30, 4 hours 37 minutes ago Alpha Copper Completes Non-Brokered Private Placement for Proceeds of $839,999.88
Published on 02/12/2025 at 22:15, 4 hours 52 minutes ago Gladstone Investment Corporation Reports Financial Results for its Third Quarter Ended December 31, 2024
Published on 02/12/2025 at 22:15, 4 hours 52 minutes ago Theralase(R) Demonstrates Effective Treatment of Herpes
Published on 02/12/2025 at 21:48, 5 hours 19 minutes ago EQS-Adhoc: technotrans releases preliminary figures for fiscal year 2024
Published on 02/12/2025 at 18:35, 8 hours 31 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 02/12/2025 at 18:00, 9 hours 7 minutes ago Private Equity Holding AG: Net Asset Value as of January 31, 2025
Published on 02/12/2025 at 17:47, 9 hours 19 minutes ago HomeToGo signs agreement to acquire Interhome: a transformative deal that pro-forma adds ∼55% to its 2024 IFRS Revenues and triples Adjusted EBITDA, leading to significant positive Free Cash Flow
Published on 02/12/2025 at 17:45, 9 hours 21 minutes ago EQS-Adhoc: HomeToGo signs definitive agreement to acquire Interhome and launches accelerated bookbuild offering for approximately €85M to complement acquisition financing
Published on 02/12/2025 at 18:58, 8 hours 8 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as at January 31, 2025
Published on 02/12/2025 at 18:13, 8 hours 53 minutes ago Disclosure of Share Capital and Voting Rights - 01.31.2025
Published on 02/12/2025 at 17:45, 9 hours 21 minutes ago Imerys-press-release-Rating-CDP-12-02-2025-VENG
Published on 02/12/2025 at 17:40, 9 hours 27 minutes ago Eiffage wins in consortium the design-build contract for the Institute of Biology and Pathology of the Bordeaux University Hospital in a deal worth €50.8 million
Published on 02/12/2025 at 17:16, 9 hours 50 minutes ago Press release relating to the publication of the other information, relating in particular to the legal, financial and accounting characteristics of Neoen